259 related articles for article (PubMed ID: 17711661)
1. [The clinical features and outcomes of immunoglobulin light-chain amyloidosis with heart involvement].
Meng L; Ding WH; Shi LB; Gong YJ; Liu ZP
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):340-3. PubMed ID: 17711661
[TBL] [Abstract][Full Text] [Related]
2. Amyloidosis and cardiac involvement.
Cacoub P; Axler O; De Zuttere D; Hausfater P; Amoura Z; Walter S; Wechsler B; Godeau P; Piette JC
Ann Med Interne (Paris); 2000 Dec; 151(8):611-7. PubMed ID: 11173703
[TBL] [Abstract][Full Text] [Related]
3. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
[TBL] [Abstract][Full Text] [Related]
4. [Cardiac amyloidosis. Invasive and noninvasive diagnosis].
Pinamonti B; Dreas L; Bussani R; Mestroni L; Silvestri F; Tanganelli P; Camerini F
G Ital Cardiol; 1987 Dec; 17(12):1016-30. PubMed ID: 3503797
[TBL] [Abstract][Full Text] [Related]
5. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.
Palladini G; Campana C; Klersy C; Balduini A; Vadacca G; Perfetti V; Perlini S; Obici L; Ascari E; d'Eril GM; Moratti R; Merlini G
Circulation; 2003 May; 107(19):2440-5. PubMed ID: 12719281
[TBL] [Abstract][Full Text] [Related]
6. Severe heart failure from light chain cardiomyopathy (cardiac amyloidosis).
Hofer JF; Wimmer G
Z Kardiol; 2003 Jan; 92(1):90-5. PubMed ID: 12545307
[TBL] [Abstract][Full Text] [Related]
7. [Cardiac amyloidosis].
Nobuoka S; Hatano S; Nagashima J; Miyake F
Nihon Rinsho; 2000 Jan; 58(1):177-80. PubMed ID: 10885309
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of clinical and imaging features of cardiac amyloidosis: a multicenter study].
Zhang L; Tang H; Chen L; Wu X; Cheng L; Wang Z; Wang Y; Huang H; Li J; Wang J; Feng B; Zhi G
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):295-302. PubMed ID: 24670437
[TBL] [Abstract][Full Text] [Related]
10. The premortem recognition of systemic senile amyloidosis with cardiac involvement.
Kyle RA; Spittell PC; Gertz MA; Li CY; Edwards WD; Olson LJ; Thibodeau SN
Am J Med; 1996 Oct; 101(4):395-400. PubMed ID: 8873510
[TBL] [Abstract][Full Text] [Related]
11. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Dubrey SW; Cha K; Anderson J; Chamarthi B; Reisinger J; Skinner M; Falk RH
QJM; 1998 Feb; 91(2):141-57. PubMed ID: 9578896
[TBL] [Abstract][Full Text] [Related]
12. Echocardiographic findings in nine patients with cardiac amyloidosis: their correlation with necropsy findings.
Nishikawa H; Nishiyama S; Nishimura S; Kondo K; Imai S; Kato K; Nakanishi S; Seki A; Yamakado T; Isaka N
J Cardiol; 1988 Mar; 18(1):121-33. PubMed ID: 3221306
[TBL] [Abstract][Full Text] [Related]
13. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival.
Prokaeva T; Spencer B; Kaut M; Ozonoff A; Doros G; Connors LH; Skinner M; Seldin DC
Arthritis Rheum; 2007 Nov; 56(11):3858-68. PubMed ID: 17968927
[TBL] [Abstract][Full Text] [Related]
14. [M-mode and two-dimensional echocardiography of 7 cases of cardiac amyloidosis].
Roudaut R; Haissaguerre M; Dallocchio M
Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1525-31. PubMed ID: 6240237
[TBL] [Abstract][Full Text] [Related]
15. Light-chain (AL) amyloidosis: diagnosis and treatment.
Sanchorawala V
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366
[TBL] [Abstract][Full Text] [Related]
16. Cardiac amyloidosis - experience in a tertiary cardiac referral centre.
Chau EM; Chow WH; Wang E; Kwong YL
Int J Cardiol; 2008 Feb; 124(2):264-6. PubMed ID: 17383027
[TBL] [Abstract][Full Text] [Related]
17. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
[TBL] [Abstract][Full Text] [Related]
18. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
[TBL] [Abstract][Full Text] [Related]
19. Histomorphometric analysis of intramyocardial vessels in primary and senile amyloidosis: epicardium versus endocardium.
Sharma PP; Payvar S; Litovsky SH
Cardiovasc Pathol; 2008; 17(2):65-71. PubMed ID: 18329550
[TBL] [Abstract][Full Text] [Related]
20. Primary (AL) amyloidosis with gastrointestinal involvement.
Madsen LG; Gimsing P; Schiødt FV
Scand J Gastroenterol; 2009; 44(6):708-11. PubMed ID: 19242859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
